I'm a Canadian journalist living in Berlin - spent more than 15 years at the CBC News in Toronto as a writer/editor and reporter/producer.  I've written loads of arts and culture stories as well as news.
Check me out:  ****

Ongoing makeover adding value to Beach Road's commercial markets

20 Mar 2019  |  The Business Times  |  English  |  Urban Transformation

The Beach Road/Ophir-Rochor Corridor is undergoing a significant transformation with a series of mixed-use, commercial, residential, and hotel projects. Key developments like South Beach, Suntec City, and DUO have revitalized the area, attracting major multinational companies and boosting office rents. Upcoming projects such as Guoco Midtown and the redevelopment of Shaw Tower are expected to further enhance the area's appeal. The region is becoming a vibrant work-live-play hub, drawing interest from investors and occupiers due to its central location, strong transport connectivity, and abundance of amenities. The future residential catchment is set to expand, supporting the retail sector and potentially extending shopping to a seven-day trading week. Investor demand is rising, with significant transactions and positive sentiment towards the area's growth prospects.

Tags:

Abbott Mastercard Sumitomo Chemicals Chevron GuocoLand Guoco Group Lian Beng Apricot Capital ARA Asset Management Chelsfield Keppel REIT RB Capital

Informative

Factuality Scale

Paul Cochrane is a freelance journalist based in Udine, Italy. He lived in Beirut, Lebanon from 2002 to 2019, and in KwaZulu-Natal, South Africa from 2019 until 2024.

He has written for over 80 publications worldwide, covering financial crime, business, higher education and skills developments, ...

Halal, health and healing: Will halalopathy bring hope to patients?

01 Oct 2023  |  Middle East Eye  |  English  |  Alternative Medicine

Palestinian scientist Jawad Alzeer, based in Switzerland, has introduced the concept of 'halalopathy,' which integrates modern medicine, halal food, spirituality, and homeopathy to provide Muslims with religious assurances about their medical treatments. The halal pharmaceutical market is growing, with companies like Chemical Company of Malaysia, AJ Biologics, and Abbott Laboratories producing halal medicines. However, the concept faces challenges, including skepticism from within the halal certification community and concerns about its religious connotations. Experts like Farah Naja and Mohammed Ghaly offer cautious support, emphasizing the need for evidence-based practices. Alzeer aims to establish halalopathic research centers and hopes the concept will gain broader acceptance, including among non-Muslims.

Tags:

Abbott Laboratories Chemical Company of Malaysia AJ Biologics

Balanced

Factuality Scale

Melissa Daniels is a journalist based in Los Angeles. She has extensive experience covering political campaigns, public policy and the judiciary — as well as feature reporting for arts and culture sections and business publications. She is available for freelance assignments as well as contract ...

Two years after a formula shortage, startups have made gains — but innovation remains difficult

12 Dec 2024  |  www.modernretail.co  |  English  |  Innovation in Baby Formula

In response to the 2022 infant formula shortage, startups like Bobbie, ByHeart, and Happy Baby Organics have expanded their market presence and production capabilities. Despite these gains, the industry faces challenges in innovation and scaling due to strict regulations and high costs. Efforts to stimulate domestic production include proposed tax incentives, while companies like Bobbie and ByHeart have invested heavily in supply chain improvements. The shortage has increased awareness of formula quality, leading to a push for more diverse and organic options in the market.

Tags:

Abbott Bobbie ByHeart Happy Baby Organics Kendamil

Balanced

Factuality Scale

Abner Dennis is a journalist based in Mombasa, Kenya.

Pain and Profit: COVID-19 Profiteers in Puerto Rico

24 Apr 2024  |  hedgeclippers.org  |  English  |  Puerto Rico

The pharmaceutical industry, particularly companies like Abbott and Roche, has been criticized for not providing COVID-19 tests in Puerto Rico despite benefiting from significant tax exemptions. Puerto Rico has faced a low rate of testing compared to the United States, and the government's decision to reopen the economy has been questioned due to the lack of an effective testing and contact tracing program. The report also discusses the pharmaceutical industry's historical and current economic impact on Puerto Rico, including the tax haven status that allows for substantial tax reductions for these companies. The article suggests that the interests of working families and those affected by the pandemic should be prioritized over the profits of pharmaceutical companies.

Tags:

Abbott Roche

Interpretive

Factuality Scale

Center-Left

Political View

Umar Farooq is a journalist based in Istanbul, Turkey.  He reports regularly for the Los Angeles Times from the region.  In the past year, his work has also appeared in Foreign Affairs, National Geographic, The Guardian, Boston Review, and The Nation.  

He received a Pulitzer Center Crisis ...

Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets

13 Dec 2023  |  www.insidermonkey.com  |  English  |  Interest Rates

Equity and fixed-income markets surged due to the Federal Reserve's indication of upcoming interest-rate reductions, boosting optimism amid easing inflation. The S&P 500 neared its all-time peak, and Apple Inc. and the Dow Jones Industrial Average reached record levels. The Federal Reserve's dot plot suggested potential interest rate cuts, influencing positive market sentiment and bond prices. The European Central Bank is also under scrutiny for potential rate cuts as inflation drops. Analysts are bullish on stocks like AT&T Inc., T-Mobile US, Inc., and others. Oppenheimer raised Costco's target price but removed it from its top pick listing due to valuation concerns. Wells Fargo increased price targets for Centene Corporation, Verizon Communications Inc., Synopsys, Inc., and Abbott Laboratories, reflecting positive outlooks and growth prospects.

Tags:

Abbott Laboratories Costco Wholesale Corporation Centene Corporation Verizon Communications Inc. Synopsys, Inc.

Informative

Factuality Scale

I am a freelance journalist based in Aarhus, Denmark. I previously spent five years in Washington, D.C., covering public health, policy and industry issues such as the COVID-19 pandemic, maternal mortality, addiction and mental health. My work has appeared in Smart Cities Dive, Morning Consult and ...

Voters Mostly Blame Supply Chain Issues for Baby Formula Shortage

22 May 2022  |  pro.morningconsult.com  |  English  |  Public Opinion

Voters attribute the baby formula shortage primarily to supply chain issues, with significant blame also placed on the FDA and Abbott Nutrition. Democrats and Republicans agree on the FDA's role but diverge on other culprits, with Democrats blaming Abbott and Republicans blaming President Joe Biden. The shortage, exacerbated by an FDA recall and Abbott's plant shutdown, has led to widespread distress, prompting emergency imports and legislative action. Abbott's market dominance and the high out-of-stock rates have intensified the crisis, affecting a significant portion of the U.S. electorate.

Tags:

Abbott Nutrition

Balanced

Factuality Scale

Center

Political View

JEAN HAKUZIMANA is a senior journalist/editor based in Concord, United States of America. If you need a work about Africa-let's talk.

Biden’s Proposed 'Asylum Ban'

08 Mar 2023  |  Spreaker  |  English  |  Elections

The article features commentary from various individuals on different topics. Lisa Parisio from the Immigrant Legal Advocacy Project (ILAP) discusses President Biden's proposed 'asylum ban,' which is likely a policy change affecting the asylum process in the United States. Mufalo Chitam provides insights into the layoffs announced by Abbott, a healthcare company, which could be related to business performance or restructuring. Violet Ikong covers the elections in Nigeria, providing analysis or updates on the electoral process and its implications for the country's future.

Tags:

Abbott

Pablo Hernández Mares is a freelance science journalist based in Guadalajara, Mexico. Proficient in audio and video editing. Specialized in creating multimedia content for science and technology. Musical producer for news and special reports.

Is early and rapid initiation of therapy for heart failure viable and safe?

16 Oct 2024  |  espanol.medscape.com  |  Spanish  |  Medical Research

The article discusses the viability and safety of early and rapid initiation of therapy for heart failure, focusing on acute heart failure and the importance of optimizing treatment during the early vulnerable period post-hospitalization. It highlights various studies, including VICTORIA, EMPULSE, and FINEARTS, which demonstrate the benefits of specific treatments like vericiguat and empagliflozin. The article emphasizes the need for improved implementation of guideline-directed medical therapy and the use of different algorithms to enhance patient outcomes. Expert opinions from Dr. Shelley Zieroth and Dr. José Antonio Magaña Serrano are featured, along with data from international studies and registries.

Tags:

Abbott AstraZeneca Bayer BMS Boehringer Ingelheim Cytokinetics Edwards Eli Lilly GSK Medtronic Merck Novartis Novo Nordisk Pfizer Vifor Pharma

Balanced

Factuality Scale

Krista Mahr is a journalist reporting on Africa, based in Johannesburg. She is an active contributor to several news organizations including the Washington Post, the Financial Times, Newsweek, Bloomberg Businessweek, Associated Press and others. 

Mahr was previously based in New Delhi, where she ...

I am a Social Communicator—Journalist living in Bogotá (Colombia) with 38 years of experience in information management, production, and dissemination.

I have worked with government entities in the International Affairs area and the road infrastructure sector. I have also participated in the ...

Parker Morse is a journalist based in Wellesley, United States of America. After starting out at Runner's World, Parker has written for Running Times, New England Runner, the Eugene Register Guard, and Reuters.

How Brands' CSR Efforts Are Helping To Rebuild Puerto Rico

05 Dec 2017  |  Forbes  |  English  |  Natural Disaster Aid

The article discusses the philanthropic response of various corporations to the devastation caused by Hurricane Maria in Puerto Rico. Companies like Starbucks, Diageo, Verizon, Google, and others have donated money and services to aid in the recovery and rebuilding efforts. The article highlights the trend of corporate donations to social causes, particularly in times of natural disasters, and how these actions are perceived by the public. It also touches on the importance of such social engagement to millennials and Gen Zers, who are key demographics for these brands. The piece mentions a 2012 report on corporate social responsibility and concludes by reflecting on the positive impact of corporate aid in disaster-stricken areas, despite some cynicism about the motives behind such outreach.

Tags:

Abbott Starbucks Diageo Verizon Google Lowe's AT&T T-Mobile JetBlue Kaiser Permanente Amgen Western Union Aetna Dish Hearts & Science P&G Rent-a-Center Cigna Starcom

Laura is an award-winning journalist, travel writer and broadcaster based in the West Midlands, U.K. 

She has worked with the BBC, Conde Nast Traveller, Euronews, The Independent Travel, Lonely Planet and Which? Travel, among others. Laura is a regular on the Which? podcasts offering travel ...

Today’s depression treatments don’t help everyone

01 Oct 2023  |  Science News  |  English  |  Medical Treatments

Depression treatments like antidepressant drugs and talk therapy are not effective for everyone, particularly those with treatment-resistant depression. Individuals like Jon Nelson and Amanda have tried numerous therapies, including electroconvulsive therapy (ECT) and transcranial magnetic stimulation, with limited success. Deep Brain Stimulation (DBS) is emerging as a potential treatment, despite past setbacks in clinical trials. The DBS program at Mount Sinai offers hope for patients who have exhausted other options. The article discusses the evolution of DBS, its applications, and the personal experiences of those undergoing the treatment.

Tags:

Abbott Laboratories St. Jude Medical Inc.

Balanced

Factuality Scale

Robyn Smith is an award-winning broadcast journalist, CNN fellow, content creator and social media producer with twenty years experience in the industry, including television news anchoring, reporting, script writing, producing, news planning and copy editing. 
She's reported from across the ...

Career Moves: Who’s going where in design, manufacturing, media and more

17 Mar 2024  |  Business of Home  |  English  |  Architecture

The article discusses recent career moves and appointments across various industries including design, manufacturing, media, and architecture. Benjamin Reynaert is now the style director at Domino magazine, leaving his previous role at Architectural Digest's AD Pro. Janice Browne has become the group publisher and chief revenue officer of Aspire One Communications. Caitlin St John is the new digital editor at Hospitality Design. In manufacturing and retail, Nicole Kapit is appointed president of Guy Regal NYC, Barbara Fuller is the vice president of marketing at Arteriors, and Christine Zampaglione is the senior director of marketing at Stanton Carpet. The Wells Companies promoted Michael Flores and hired Betty Tuva. Lynn Galvin is the new showroom manager at Samuel & Sons. Coastal Shower Doors named Robbie Dedrick as national sales manager. Walker Zanger hired Greg Rang, Anita Crosby, and Nova Carter for their regional sales teams. In architecture and design, Wilson Associates welcomed Danielle Hirsch, AO hired Paolo Leon and Lara McKissick, Stonehill Taylor named Sara Duffy and Mark Hayes as principals, and Charles Hirschhorn was appointed president of Otis College of Art and Design.

Tags:

Wells Abbott Domino magazine Architectural Digest AD Pro Hearst Design Group One Kings Lane Traditional Home Martha Stewart Living Aspire One Communications Aspire Design and Home magazine Galerie Luxe Interiors + Design Cottages & Gardens Business of Home Guy Regal NYC Incollect Newel Arteriors St. Charles New York LG’s Signature Kitchen Suite Stanton Carpet Kravet The Wells Companies Classic Cloth Rose Cumming Chintzes Wells Textiles Dessin Fournir Samuel & Sons Eleish Van Breems Farrow & Ball Arhaus New England Home Kips Bay Boys & Girls Club Donghia Coastal Shower Doors Walker Zanger Wilson Associates AO Stonehill Taylor Otis College of Art and Design AEG Television

Victoria Smith is a broadcast journalist, reporter, presenter, VJ and editor based in London, United Kingdom.
She has over 25 years experience in TV, radio, digital and print and is also a media trainer.
Victoria works as a UK correspondent for Euronews and a reporter/producer for Good Morning ...

Interview with the CEO of MARACA International

15 Jun 2020  |  www.medicaldevice-network.com  |  English  |  Clinical Services

MARACA International, a Belgium-based consulting company, specializes in regulatory, quality, and clinical services for medical device and in-vitro diagnostic device companies. Founded by Dr. Luc Van Hove, the company aims to support the introduction of nanotechnology-based devices to European and American markets. MARACA has been recognized for its high-quality services and has adapted to the COVID-19 pandemic by participating in efforts to bring compliant medical devices and tests to market quickly. The company is also involved in regulatory discussions and scientific sessions to address challenges in the medical device industry.

Tags:

Abbott Laboratories MARACA International Biocartis

Balanced

Factuality Scale

Candice Tang is a multi-media journalist based in Hong Kong.

Abbott Commences MitraClip Clinical Trial for Underserved Patient Population

16 Jan 2020  |  Xtalks  |  English  |  Clinical Trials

Abbott has seen success with its cardiac medical device, MitraClip, designed to treat mitral regurgitation (MR). The device, approved by the FDA in 2013, has undergone several iterations and is now being tested in a new clinical trial, REPAIR-MR, to assess its effectiveness for patients who could undergo open heart surgery. The trial will enroll 500 patients across the US, Canada, and Europe. MitraClip has been shown to be cost-effective and improve quality of life in previous studies. The outcome of the trial could influence the adoption of MitraClip in clinical practice, especially with the potential revision of the National Coverage Determination for transcatheter mitral valve repair procedures by the Centers for Medicare & Medicaid.

Tags:

Abbott MitraClip

Veteran reporter based on Parliament Hill in Ottawa, Canada filing regularly to print, web, radio, television and magazines.

Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy

25 Apr 2024  |  eurointervention.pcronline.com  |  English  |  Biomechanics

The ABSORB III Imaging substudy biomechanical analysis revealed that patients randomized to Bioresorbable vascular scaffolds (BVS) compared to everolimus-eluting stents (XV) had no significant differences in post-stent intravascular ultrasound characteristics or underexpansion. However, BVS was associated with a significantly greater proportion of stents with low mean wall shear stress (WSS) and lower WSS values across the stent compared to XV. Low stent WSS was linked to lower contrast velocity, less residual plaque, less stent underexpansion, higher eccentricity index, and BVS placement. Independent predictors of greater length of low WSS were hypertension, BVS placement, lower blood velocity, less residual plaque, and less stent underexpansion. The study suggests that the design of BVS, particularly the thicker strut size, may predispose post-stented vessels to low WSS, potentially mediating adverse healing conditions and increased risk of scaffold thrombosis.

Tags:

Abbott Vascular

Informative

Factuality Scale

Sakshi Udavant is a freelance journalist with an academic background in psychology. 

She covers mental health, technology, finance, business, and related topics for industry-leading brands like PayPal, Mozilla, NBCU, Insider, Digital Trends, InsideHook, Chicago Tribune, and others found here: ***...

Major factory construction projects to watch in 2023

23 Jan 2023  |  www.manufacturingdive.com  |  English  |  Economic Development

In 2023, several companies are launching major manufacturing construction projects in the U.S., including TSMC's $40 billion semiconductor plants in Arizona, Intel's $20 billion facility in Ohio, and Samsung's $17 billion plant in Texas. These projects aim to strengthen U.S. supply chains and push towards sustainability. Other notable projects include Form Energy's iron-air battery systems in West Virginia, Abbott's nutritional powder factory in Ohio, Siemens' EV charger plant in Texas, and Enel's upcoming solar PV cell and panel facility. The Biden Administration's CHIPS and Science Act is incentivizing these investments, which are expected to create thousands of jobs and bolster economic growth.

Tags:

Abbott TSMC Intel Samsung Form Energy Siemens Enel

Factual

Factuality Scale